Total Payments
$6,450
2024 Payments
$1,593
Companies
31
Transactions
280
Medicare Patients
2,127
Medicare Billing
$297,996
Payment Breakdown by Category
Food & Beverage$6,438 (99.8%)
Education$12.33 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,438 | 279 | 99.8% |
| Education | $12.33 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,424 | 71 | $0 (2024) |
| Dexcom, Inc. | $836.92 | 32 | $0 (2024) |
| Lilly USA, LLC | $581.63 | 36 | $0 (2024) |
| Medtronic, Inc. | $568.07 | 12 | $0 (2023) |
| Abbott Laboratories | $388.52 | 21 | $0 (2024) |
| Amgen Inc. | $315.23 | 18 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $294.38 | 3 | $0 (2024) |
| Mannkind Corporation | $264.90 | 18 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $256.81 | 8 | $0 (2022) |
| Insulet Corporation | $219.72 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,593 | 62 | Novo Nordisk Inc ($235.08) |
| 2023 | $1,524 | 65 | Dexcom, Inc. ($361.43) |
| 2022 | $1,553 | 67 | Novo Nordisk Inc ($469.48) |
| 2021 | $1,780 | 86 | Novo Nordisk Inc ($395.21) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $99.87 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Biological | ||||||
| 10/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: Insulin Pump | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Diabetes Care | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $47.13 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $118.78 | General |
| Category: Automated insulin delivery system | ||||||
| 08/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Bone Health | ||||||
| 08/15/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 08/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Automated insulin delivery system | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 558 | 2,858 | $268,357 | $85,009 |
| 2022 | 6 | 572 | 2,572 | $259,042 | $79,109 |
| 2021 | 7 | 545 | 2,385 | $284,818 | $86,173 |
| 2020 | 6 | 452 | 775 | $188,361 | $47,706 |
Total Patients
2,127
Total Services
8,590
Medicare Billing
$297,996
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 1,920 | $84,480 | $35,198 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 238 | 426 | $74,976 | $21,228 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 263 | $68,380 | $20,765 | 30.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 73 | 164 | $22,632 | $3,571 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $13,200 | $3,332 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 17 | $1,819 | $609.60 | 33.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 35 | $2,870 | $305.60 | 10.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 16 | 1,680 | $73,920 | $28,411 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 302 | $78,520 | $21,941 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 371 | $65,296 | $20,409 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $20,000 | $5,112 | 25.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 63 | 133 | $18,354 | $2,920 | 15.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 36 | $2,952 | $314.52 | 10.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 282 | 594 | $154,440 | $47,458 | 30.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 19 | 1,440 | $63,360 | $22,572 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $25,200 | $6,367 | 25.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 115 | $20,240 | $6,290 | 31.1% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 61 | 132 | $18,216 | $3,015 | 16.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 30 | $2,460 | $283.91 | 11.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $902.00 | $187.11 | 20.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 249 | 525 | $136,500 | $35,829 | 26.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 60 | 60 | $24,000 | $5,810 | 24.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 63 | 70 | $12,320 | $2,929 | 23.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 45 | 84 | $11,592 | $1,901 | 16.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 23 | $2,883 | $1,035 | 35.9% |
About Beth Hite, NP-C
Beth Hite, NP-C is a Family healthcare provider based in Salem, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1073040200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Hite, NP-C has received a total of $6,450 in payments from pharmaceutical and medical device companies, with $1,593 received in 2024. These payments were reported across 280 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,438).
As a Medicare-enrolled provider, Hite has provided services to 2,127 Medicare beneficiaries, totaling 8,590 services with total Medicare billing of $297,996. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Salem, VA
- Active Since 05/18/2017
- Last Updated 01/27/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1073040200
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $623.48
- Ozempic (Drug) $573.62
- INTELLIS ADAPTIVESTIM (Device) $338.93
- t:slim X2 Insulin Pump with Control-IQ (Device) $294.38
- TRULICITY (Drug) $270.83
- AFREZZA (Drug) $264.90
- FREESTYLE LIBRE 3 (Device) $240.81
- FARXIGA (Drug) $220.14
- Omnipod (Device) $219.72
- Rybelsus (Drug) $217.98
- DEXCOM G6 TRANSMITTER (Device) $213.44
- JARDIANCE (Drug) $211.42
- INSPIRE (Device) $201.32
- EVENITY (Biological) $199.83
- RYBELSUS (Drug) $187.95
- Wegovy (Drug) $179.83
- Saxenda (Drug) $151.12
- iLet Bionic Pancreas (Device) $136.85
- Veozah (Drug) $117.09
- InPen (Device) $116.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Salem
Dr. Christopher Gessel, Np, NP
Family — Payments: $19,312
Family $19,312
Pamela Price, Np, NP
Family — Payments: $15,044
Family $15,044
Neeta Vorst, Fnp, FNP
Family — Payments: $14,287
Family $14,287
Mrs. Kelli Farm, Np, NP
Family — Payments: $12,377
Family $12,377
Mrs. Kelly Link, Np-C, NP-C
Family — Payments: $8,038
Family $8,038
Sarah Markwood, Fnp, FNP
Family — Payments: $4,890
Family $4,890